Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

Autor: Francesc, Formiga, Manuel, Rubio-Rivas, José María, Mora-Luján, Samara Campos, Escudero, Rosa Fernandez Madera, Martinez, Manuel, Mendez-Bailón, Pedro Durán-Del, Campo, Andrea Riaño, Pérez, Francisco-Javier, García-Sánchez, José Nicolás, Alcalá-Pedrajas, Sergio Arnedo, Hernández, Almudena Hernández, Milian, Ana Latorre, Díez, Ricardo Gil, Sánchez, Ramon, Boixeda, Julio, Vicente, Begoña, Cortes, Carmen Mella, Pérez, María Esther Guisado, Espartero, José López, Castro, Santiago Rodríguez, Suárez, Jose F, Varona, Ricardo, Gomez-Huelgas, Jose Manuel, Ramos-Rincón, José F Varona, Arche

Publikováno v: INTERNAL AND EMERGENCY MEDICINE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-FISABIO. Repositorio Institucional de Producción Científica
Internal and Emergency Medicine

Acetylsalicylic acid (ASA) is widely used in the treatment and prevention of cardiovascular disorders. Our objective is to evaluate its possible protective role, not only in mortality but also in other aspects such as inflammation, symptomatic thromb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92bf6fbd7e8d89d5d010937672d69a0e
https://doi.org/10.1007/s11739-021-02870-1